McDonald’s shares took successful this week after analysts painted a sobering image of how weight-loss medication would possibly reshape the quick-meals panorama. The inventory dropped as a lot as 1.7% following a dramatic two-notch downgrade from Redburn Atlantic, which slashed its score from purchase to promote, based on CBS Information. The perpetrator? These urge for food-suppressing drugs everybody’s speaking about.
